Turkish Capital Markets Board Assigns Two Banks to 131 Fund Liquidation Processes

The CMB's assignment of two banks in the liquidation process of 131 funds is not a development that directly affects ISCTR's operational or financial performance. The news is of a sectoral regulatory and appointment nature and does not contain a stock-specific signal. Technical indicators are mixed: the price has increased by 9.41% in 24 hours and the RSI at 60.7 is approaching overbought territory, but the MACD is negative and below the signal line. The price is above the SMA20 but below the SMA50, indicating a short-term recovery but continued medium-term resistance. The impact of the news may be limited; however, profit-taking may be seen after the strong daily rise.

TERA stock has fallen 9.97% in the last 24 hours to 181.5, with RSI14 at 19.2, indicating oversold territory. MACD is negative and below the signal line, and the stock is trading well below its SMA20 and SMA50, signaling strong downward momentum. The SPK's appointment of two banks to liquidate 131 funds has heightened market concerns over liquidity and confidence, which could sustain selling pressure in the short term. However, oversold conditions may trigger a rebound; nonetheless, the overall outlook remains bearish. Although the news's direct relevance to TERA is unclear, sector-wide risk perception could negatively impact the stock.

The appointment of two banks by the CMB in the liquidation process of 131 funds stands out as a regulatory action in the sector. The news does not contain concrete information that would directly affect GARAN's operational or financial performance; therefore, its short-term impact may be limited. Technical indicators point to strong momentum: the stock has risen 9.59% in the last 24 hours, RSI is at 64, and MACD is above the signal line. The price is above the SMA20 but close to the SMA50, indicating that the upward trend may continue in the short term but is approaching a resistance zone. While the news impact is neutral, the current technical outlook is positive; however, since there is no news-driven catalyst, caution is warranted.